Strategic Blueprint’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $804K | Buy |
1,807
+309
| +21% | +$138K | 0.04% | 344 |
|
|
2025
Q1 | $726K | Buy |
1,498
+25
| +2% | +$12.1K | 0.04% | 345 |
|
|
2024
Q4 | $593K | Buy |
1,473
+386
| +36% | +$155K | 0.04% | 371 |
|
|
2024
Q3 | $506K | Buy |
1,087
+7
| +0.6% | +$3.26K | 0.03% | 395 |
|
|
2024
Q2 | $506K | Buy |
1,080
+120
| +13% | +$56.2K | 0.03% | 376 |
|
|
2024
Q1 | $401K | Buy |
960
+304
| +46% | +$127K | 0.03% | 427 |
|
|
2023
Q4 | $267K | Buy |
+656
| New | +$267K | 0.02% | 486 |
|
|
2021
Q3 | – | Sell |
-59
| Closed | -$12K | – | 1283 |
|
|
2021
Q2 | $12K | Buy |
+59
| New | +$12K | ﹤0.01% | 919 |
|
|
2020
Q4 | – | Sell |
-1,278
| Closed | -$348K | – | 264 |
|
|
2020
Q3 | $348K | Buy |
+1,278
| New | +$348K | 0.11% | 154 |
|